178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Physical activity reduces cardiovascular risk in rheumatic patients

Physical activity reduces cardiovascular risk in rheumatic patients

by FAPESPPeople with diseases such as rheumatoid arthritis and lupus are more likely to have heart attacks, angina, and strokes. A review of the scientific literature on the subject shows that re

Physical activity reduces cardiovascular risk in rheumatic patients

by FAPESPPeople with diseases such as rheumatoid arthritis and lupus are more likely to have heart attacks, angina, and strokes. A review of the scientific literature on the subject shows that re
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
Compound found to trigger innate immunity against viruses

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule
Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther
Cell-compressing technique a new path in immunotherapy

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul
COVID-19, MIS-C and Kawasaki disease share same immune response

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun
Rituximab retreatment at clinical relapse cost-effective in RA

Rituximab retreatment at clinical relapse cost-effective in RA

(HealthDay)—Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis (RA), according to a study published in the July is

Rituximab retreatment at clinical relapse cost-effective in RA

(HealthDay)—Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis (RA), according to a study published in the July is
Increased use of partial knee replacement could save the NHS £30 million per year

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th
Program may help patients with rheumatic diseases quit smoking

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli
1 billion people worldwide will suffer from arthritis by 2050

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity
'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
Researchers discover key metabolic process responsible for rapid immune responses

Researchers discover key metabolic process responsible for rapid immune responses

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) identified a key metabolite in cells that helps direct i

Researchers discover key metabolic process responsible for rapid immune responses

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) identified a key metabolite in cells that helps direct i